Linezolid Stada

Linezolid, the active ingredient in Linezolid Stada, is an oxazolidinone antibiotic presented as an oral tablet for oral use. It treats serious bacterial infections, including those caused by resistant Gram‑positive organisms, in adult patients. GNH USA supplies Linezolid Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by susceptible Gram‑positive bacteria. - Skin and soft tissue infections: eradicates Staphylococcus aureus, including MRSA, improving wound healing. - Community‑acquired pneumonia: targets Streptococcus pneumoniae and atypical pathogens, reducing respiratory symptoms. - Nosocomial pneumonia: effective against hospital‑acquired Gram‑positive pathogens, aiding recovery. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides an alternative to vancomycin for resistant strains. - Vancomycin‑resistant Enterococcus (VRE) infections: offers activity against resistant enterococci when other options are limited.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Insomnia: difficulty sleeping.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced red blood cell levels. - Peripheral neuropathy: tingling or numbness in extremities. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: accumulation of lactate causing metabolic disturbance. - Optic neuropathy: visual disturbances, potentially irreversible.

When prescribing Linezolid, clinicians should consider several safety measures. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes regularly. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Myelosuppression: perform routine blood counts to detect cytopenias. - Pregnancy: safety unknown; weigh potential benefits against risks. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin toxicity. - Rifampicin: induces metabolism, reducing linezolid plasma levels.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR, requiring coagulation monitoring. - Phenytoin: may lower linezolid concentrations, affecting efficacy. - Antacids containing magnesium or aluminum: can impair absorption, consider timing adjustments.